TR-C 19

N/A

Report date: 2024/07/02 11:22:35
NME

Base Information

Drug NameTR-C 19
Drug Alias NameTR-C-19TR-C 19
ClassificationOther
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVSY Biotechnology GmbH
China Registration ClassN/A

Develop Information

Active CompaniesVSY Biotechnology GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A